Advertisement

Topics

Novel Compound Passes Phase III Test in Acute Migraine

07:30 EDT 4 Aug 2017 | MedPageToday

(MedPage Today) -- First-in-class agent lasmiditan targets trigeminal serotonin receptors

Original Article: Novel Compound Passes Phase III Test in Acute Migraine

NEXT ARTICLE

More From BioPortfolio on "Novel Compound Passes Phase III Test in Acute Migraine"

Quick Search
Advertisement
 

Relevant Topic

Selective serotonin reuptake inhibitors SSRIs
Serotonin and norepinephrine reuptake inhibitors (SNRIs) are a class of medications that are effective at easing depression symptoms. SNRIs are also sometimes used to treat other conditions such as anxiety and nerve pain. How SNRIs work Serotonin (se...